Barely Significant
← all excerpts

Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR-HF2 DZHK05 trial): Sex-specific outcomes.

Eur J Heart Fail · 2025 · PMC12765045 · PMID 40740027

Europe PMCDOI
2
hedged sentences
0.2000
closest p · 4.0× alpha
0.2000
boldest claim

The sentences

did not reach statistical significancep = 0.20not close (p > 0.1)
In men, the improvement in the EQ‐5D score from baseline to 12 months in the treatment group compared with the placebo group did not reach statistical significance (mean difference: +0.019; 95% CI −0.010–0.049, p = 0.20).

also in 53,799 other papers

reached borderline significanceno p-value reported
The p ‐value for a treatment‐by‐sex interaction reached borderline significance for two of the three primary endpoints ( p for interaction 0.13, 0.30, and 0.104, respectively).

also in 96 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.